ASRS
KROS icon

Arizona State Retirement System’s Keros Therapeutics KROS Stock Holding History

Arizona State Retirement System’s Portfolio KROS Stock Details KROS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-8,312
Closed -$483K – 2155
2024
Q3 		$483K Buy
8,312
+235
+3% +$11.6K ﹤0.01% 1506
2024
Q2 		$369K Buy
8,077
+1,130
+16% +$60.7K ﹤0.01% 1602
2024
Q1 		$460K Buy
6,947
+1,142
+20% +$67.7K ﹤0.01% 1497
2023
Q4 		$231K Buy
+5,805
New +$182K ﹤0.01% 1878
2023
Q3 		– Sell
-5,611
Closed -$225K – 2182
2023
Q2 		$225K Buy
5,611
+823
+17% +$36.1K ﹤0.01% 1885
2023
Q1 		$204K Buy
4,788
+428
+10% +$21.6K ﹤0.01% 1926
2022
Q4 		$209K Buy
+4,360
New +$204K ﹤0.01% 1880
2022
Q1 		– Sell
-3,455
Closed -$202K – 2249
2021
Q4 		$202K Buy
+3,455
New +$172K ﹤0.01% 2084

Other funds holding KROS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Arizona State Retirement System's KROS Position: Q4 2024 in Review

Arizona State Retirement System sold out of Keros Therapeutics (KROS) in Q4 2024, closing a stake of 8,312 shares — an estimated $483K sold.

Arizona State Retirement System first reported a position in KROS in Q4 2021 and held it in 8 quarters. The position peaked at $483K in Q3 2024. 161 funds tracked by Wall St. Rank hold KROS as of Q4 2024.

  • Arizona State Retirement System reported no remaining Keros Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Arizona State Retirement System sold 8,312 Keros Therapeutics shares in Q4 2024, an estimated $483K.
  • Arizona State Retirement System first reported a position in Keros Therapeutics in Q4 2021 and held it in 8 quarters.
  • Arizona State Retirement System's Keros Therapeutics position peaked at $483K in Q3 2024.
  • 161 funds tracked by Wall St. Rank held Keros Therapeutics as of Q4 2024.

Based on Arizona State Retirement System's 13F filing for Q4 2024, filed 6 Feb 2025.